Showing 391 - 400 of 575 for "Shearn Delamore & Co" with applied filters
23 October 2020 by
On 23 October 2020, the Malaysian government gazetted the Temporary Measures for Reducing the Impact of Coronavirus Disease 2019 (Covid19) Act 2020 (“Covid-19 Act”). This Act, as evident from its name, is meant to provide temporary measures to ease the impact of Covid19 on various sectors and industries in Malaysia.
19 March 2024 by
asialaw's LOTM for February 2024 is...
20 February 2024 by
asialaw's DOTM for January 2024 is...
20 October 2023 by
India's practitioner, Vijay Parthasarathi, wins our October Lawyer of the Month for his exceptional contribution to the country's first-of-its-kind Qualified Institutional Placement (QIP).
19 September 2023 by
September 2023's Lawyer of the Month is a legal expert who has demonstrated exceptional excellence in their field. This article takes a closer look at their achievements and what sets them apart.
18 September 2023 by
We are pleased to announce the successful conclusion of the highly prestigious sixth annual asialaw Awards, which took place yesterday at the esteemed Marina Bay Sands in Singapore.
07 August 2023 by
asialaw proudly reveals the shortlist for its 2023 awards, spotlighting the leading talent set to compete across Asia's legal communities. The anticipation builds as we announce the elite group of firms in contention this year. Our honorees represent the best of the best, demonstrating remarkable innovation and impact.
02 August 2023 by
This article analyses the concept of comparative advertising within the domain of the Trademark regime, studying the various components involved, including the statutory laws and judicial pronouncements in India.
20 July 2023 by
July 2023's Lawyer of the Month is a legal expert who has demonstrated exceptional excellence in their field. This article takes a closer look at their achievements and what sets them apart.
11 July 2023 by
RNA molecules have been utilized as therapeutic and research tools for more than two decades, with the usage ranging from in vitro transcribed (IVT) mRNA, small interference RNA (siRNA), RNA aptamers, riboswitches, and antisense RNA to the recently developed mRNA vaccines.
